NHI logo

NATL HEALTH INVESTORS INC

NHINYSE
πŸ† #1210 by market capEarnings Nov 4US Equity
$964.64β–² $1.54 (+0.16%)
Simulated price
1hβ€”
24hβ–² 0.2%
7dβ€”
14dβ€”
30dβ€”
1yβ€”
🏦Market Cap
$3.59B
Small Cap
πŸ“ˆRevenue Growth (YoY)
+17.1%
Healthy
πŸ“ŠGross Margin
77.8%
High
πŸ’΅FCF Margin
14.5%
Healthy
βš–οΈP/S Ratio
9.0x
Elevated
Otter Score
52
Weak
No chart data available for NHI.

Trading Snapshot

Day Range
$954.16 – $981.43
52-Week Range
$67.94 – $91.38
Volume
$1.78B
Avg Volume
$2.19B
Shares Outstanding
48.5M
Next Earnings
Aug 30, 2026

Fundamentals Snapshot

Annual Revenue
$379M
Last Q Revenue
$121M
P/E Ratio
24.3
P/S Ratio
9.0x
EPS (TTM)
$3.10
Dividend Yield
4.81%

Why Investors Own NHI

  • βœ“High-growth profile β€” revenue up +35.0% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 49% gross margin and 22% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)
$379Mβ–² +37.9% YoY
Gross Margin (TTM)
49.2%β–² +4.3% YoY
Operating Income (TTM)
$106Mβ–² +37.9% YoY
Free Cash Flow (TTM)
$82Mβ–² +37.9% YoY

About NATL HEALTH INVESTORS INC

Established in 1991, National Health Investors, Inc. (NYSE: NHI) operates as a real estate investment trust (REIT) primarily focused on providing capital for senior living and medical real estate assets. The company facilitates this through diverse financing options, including sale-leaseback arrangements, joint ventures, and various debt instruments such as mortgage and mezzanine loans, targeting properties that cater to both essential care needs and discretionary services. NHI's broad holdings feature independent living, assisted living, and memory care facilities, as well as entrance-fee retirement communities, skilled nursing homes, medical office complexes, and specialized hospitals.

🦦

Otter Score Breakdown

β“˜
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
Overall Score
Weak
52/100

Analyst Price Target

β“˜
Average Target
$1,054.57
β–² +9.3% Upside
High Target$1,290.93
Low Target$844.15
Based on 37 analysts

Latest News & Updates